Per-Uno Malmstrom
Overview
Explore the profile of Per-Uno Malmstrom including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
165
Citations
3475
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
2.
Prip F, Lamy P, Lindskrog S, Strandgaard T, Nordentoft I, Birkenkamp-Demtroder K, et al.
Nat Genet
. 2025 Jan;
57(1):115-125.
PMID: 39753772
Understanding the molecular landscape of nonmuscle-invasive bladder cancer (NMIBC) is essential to improve risk assessment and treatment regimens. We performed a comprehensive genomic analysis of patients with NMIBC using whole-exome...
3.
Liedberg F, Gardmark T, Hagberg O, Aljabery F, Strock V, Hosseini A, et al.
Eur Urol Oncol
. 2024 Aug;
8(1):119-125.
PMID: 39143001
Background And Objective: It has been suggested that urinary tract infections (UTIs) are associated with delayed diagnosis of bladder cancer (BC). Our aim was to investigate prediagnostic treatments related to...
4.
Jahnson S, Gardmark T, Hosseini A, Jerlstrom T, Liedberg F, Malmstrom P, et al.
Bladder Cancer
. 2024 Jul;
7(2):161-171.
PMID: 38994539
Background: Routine VTE prophylaxis within 30 days of radical cystectomy (RC) for urinary bladder cancer (UBC) is used to protect from venous thromboembolism (VTE). However, randomized studies and nationwide population-based...
5.
Kerzeli I, Lord M, Doroszko M, Elgendy R, Chourlia A, Stepanek I, et al.
PLoS One
. 2024 May;
19(5):e0304890.
PMID: 38820327
[This corrects the article DOI: 10.1371/journal.pone.0253178.].
6.
Holmberg L, Skogmar S, Garmo H, Hagberg O, Haggstrom C, Gardmark T, et al.
BJU Int
. 2024 Feb;
134(2):229-238.
PMID: 38403809
Objectives: To investigate the cumulative incidence proportion of disseminated or local Bacillus Calmette-Guérin (BCG) infections after adjuvant BCG instillations in patients with non-muscle-invasive bladder cancer (NMIBC). Patients And Methods: We...
7.
Wang E, Hagberg O, Malmstrom P
PLoS One
. 2023 Dec;
18(12):e0292174.
PMID: 38096211
Background: Alzheimer's disease (AD) affects 50 million people worldwide. The immune system plays a major role in the pathogenesis of AD. Several retrospective analyses have reported a decreased risk of...
8.
Malmstrom P, Truls G
Scand J Urol
. 2023 Nov;
58:109-114.
PMID: 37987210
Objectives: To test the hypothesis that the Swedish national policy of abandoning testing for asymptomatic microscopic haematuria (AMH) introduced in 1999 did not adversely affect the prognosis of patients with...
9.
Kerzeli I, Kostakis A, Turker P, Malmstrom P, Hemdan T, Mezheyeuski A, et al.
BMC Cancer
. 2023 Jun;
23(1):605.
PMID: 37391708
Background: Urothelial bladder cancer is most frequently diagnosed at the non-muscle-invasive stage (NMIBC). However, recurrences and interventions for intermediate and high-risk NMIBC patients impact the quality of life. Biomarkers for...
10.
Bergengren O, Belozerov A, Bill-Axelson A, Garmo H, Hagberg O, Aljabery F, et al.
Eur J Surg Oncol
. 2023 Feb;
49(4):868-874.
PMID: 36759262
Introduction: We aimed to compare short term outcomes after robot assisted radical cystectomy (RARC) and open radical cystectomy (ORC) for urinary bladder cancer in a large population. Materials And Methods:...